Literature DB >> 28471480

MicroRNA-142 controls thymocyte proliferation.

Alexander Mildner1, Elik Chapnik2, Diana Varol1, Tegest Aychek1, Nardi Lampl1, Natalia Rivkin2, Anita Bringmann1, Franziska Paul1, Sigalit Boura-Halfon1, Yifat Segal Hayoun1, Zohar Barnett-Itzhaki1, Ido Amit1, Eran Hornstein2, Steffen Jung1.   

Abstract

T-cell development is a spatially and temporally regulated process, orchestrated by well-defined contributions of transcription factors and cytokines. Here, we identify the noncoding RNA miR-142 as an additional regulatory layer within murine thymocyte development and proliferation. MiR-142 deficiency impairs the expression of cell cycle-promoting genes in mature mouse thymocytes and early progenitors, accompanied with increased levels of cyclin-dependent kinase inhibitor 1B (Cdkn1b, also known as p27Kip1 ). By using CRISPR/Cas9 technology to delete the miR-142-3p recognition element in the 3'UTR of cdkn1b, we confirm that this gene is a novel target of miR-142-3p in vivo. Increased Cdkn1b protein expression alone however was insufficient to cause proliferation defects in thymocytes, indicating the existence of additional critical miR-142 targets. Collectively, we establish a key role for miR-142 in the control of early and mature thymocyte proliferation, demonstrating the multifaceted role of a single miRNA on several target genes.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Posttranscriptional control; Thymocyte development; microRNAs

Mesh:

Substances:

Year:  2017        PMID: 28471480     DOI: 10.1002/eji.201746987

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Functional Role of MicroRNAs in Thymocyte Development.

Authors:  Lin Hu; Ling Mao; Shiming Liu; Juanjuan Zhao; Chao Chen; Mengmeng Guo; Zhixu He; Jie Yang; Wei Xu; Lin Xu
Journal:  Int Arch Allergy Immunol       Date:  2019-03-12       Impact factor: 2.749

Review 2.  Non-coding RNAs in CD8 T cell biology.

Authors:  Alexandria C Wells; Elena L Pobezinskaya; Leonid A Pobezinsky
Journal:  Mol Immunol       Date:  2020-02-18       Impact factor: 4.407

Review 3.  Control of Immunoregulatory Molecules by miRNAs in T Cell Activation.

Authors:  Ana Rodríguez-Galán; Lola Fernández-Messina; Francisco Sánchez-Madrid
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

4.  MicroRNA-142 Critically Regulates Group 2 Innate Lymphoid Cell Homeostasis and Function.

Authors:  Luke B Roberts; Geraldine M Jowett; Emily Read; Tomas Zabinski; Rita Berkachy; Murray E Selkirk; Ian Jackson; Umar Niazi; Nelomi Anandagoda; Masatake Araki; Kimi Araki; Jagath Kasturiarachchi; Chela James; Tariq Enver; Rachael Nimmo; Rita Reis; Jane K Howard; Joana F Neves; Graham M Lord
Journal:  J Immunol       Date:  2021-05-21       Impact factor: 5.422

Review 5.  Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver.

Authors:  Anuradha Pandit; Yasmin Begum; Priyanka Saha; Amit Kumar Srivastava; Snehasikta Swarnakar
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

6.  MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis.

Authors:  Maria C Trissal; Terrence N Wong; Juo-Chin Yao; Rahul Ramaswamy; Iris Kuo; Jack Baty; Yaping Sun; Gloria Jih; Nishi Parikh; Melissa M Berrien-Elliott; Todd A Fehniger; Timothy J Ley; Ivan Maillard; Pavan R Reddy; Daniel C Link
Journal:  Cancer Res       Date:  2018-05-03       Impact factor: 13.312

Review 7.  MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease.

Authors:  Christian Koenecke; Andreas Krueger
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

8.  miRNA miR-21 Is Largely Dispensable for Intrathymic T-Cell Development.

Authors:  Heike Kunze-Schumacher; Samantha J Winter; Esther Imelmann; Andreas Krueger
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

9.  MicroRNA-142-3p improves vascular relaxation in uremia.

Authors:  Máté Kétszeri; Andrijana Kirsch; Bianca Frauscher; Foteini Moschovaki-Filippidou; Agnes A Mooslechner; Alexander H Kirsch; Corinna Schabhuettl; Ida Aringer; Katharina Artinger; Gudrun Pregartner; Robert Ekart; Silva Breznik; Radovan Hojs; Walter Goessler; Irene Schilcher; Helmut Müller; Barbara Obermayer-Pietsch; Saša Frank; Alexander R Rosenkranz; Philipp Eller; Kathrin Eller
Journal:  Atherosclerosis       Date:  2018-11-10       Impact factor: 5.162

10.  Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes.

Authors:  A Marshall; J Kasturiarachchi; P Datta; Y Guo; E Deltcheva; C James; J Brown; G May; N Anandagoda; I Jackson; J K Howard; E Ghazaly; S Brooks; A Khwaja; M Araki; K Araki; D Linch; G M Lord; T Enver; R Nimmo
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.